— CATEGORY · 3 COMPOUNDS

Incretin & receptor research compounds

Metabolic research peptides are studied for their roles in regulating energy balance, insulin response, glucose metabolism, and mitochondrial signalling across preclinical and in vitro models.

This category includes Retatrutide, a next-generation triple-receptor agonist simultaneously engaging GLP-1, GIP, and glucagon pathways; Mots-C, a mitochondrially-encoded peptide investigated for AMPK activation; and NAD+, the foundational coenzyme at the centre of sirtuin enzyme activity and cellular energy metabolism. Research across this category examines receptor-mediated signalling, metabolic gene expression, and the interactions between nutrient-sensing pathways.

For in vitro research use only. Compounds in this category are not for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compounds in incretin & receptor research

Research bundles containing incretin & receptor research compounds

Explore all curated multi-compound bundles View all 10 research bundles →

Frequently asked — incretin & receptor research

What compounds does Velox Peptides supply for incretin & receptor research?
Velox Peptides supplies 3 research compounds in this category: Mots-C, NAD+, Retatrutide. All are HPLC-verified by a third-party laboratory.
Are these peptides for human use?
No. All compounds supplied by Velox Peptides are strictly for in vitro research use by qualified researchers. They are not medicinal products and are not for human or veterinary consumption.
How are research peptides supplied?
Research compounds are supplied as lyophilised (freeze-dried) powders in sterile vials for reconstitution with bacteriostatic water prior to research use. See our reconstitution calculator for concentration and volume calculations.
Is purity documentation available?
Yes. Batch documentation is available on request. Previous batch CoAs are available in our CoA library.
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.